Editas Medicine
Editas Medicine is a Massachusetts-based biotechnology company that develops and commercializes gene-edited therapeutics for the treatment of ocular diseases and cancer.
Business Model:
Revenue: $25.6M
Employees: 201-500
Industries / Tags:
Detailed Editas Medicine Information
Geographic Data
Address: 11 Hurley Street
City: Cambridge
State: MA
Zip: 02141
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$231M
Raised Total:$473M
Social
Metrics
1,649,160Website Global Rank
14,499Website Monthly Traffic
Twitter Followers
Description
Editas Medicine is a Massachusetts-based biotechnology company that develops and commercializes gene-edited therapeutics for the treatment of ocular diseases and cancer.
Contact Phone:
+16174019000
Contact Email:
Editas Medicine went public on 2/3/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/3/2016
IPO Valuation:
$571M
Ticker Symbol:
EDIT
IPO Price:
$16/share
Amount Raised:
$94M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
